Incontinence and other urinary problems after prostate cancer treatment can be eased with Kegel exercises, bladder training, ...

Policymakers should prepare now for the likelihood that the decision will in some degree at least open the door to challenges to all health care provided only through speech. State licensing boards ...

Learn the difference between induction and maintenance phases in ANCA-associated vasculitis (AAV) treatment, including what to expect from medications like rituximab (Rituxan).

Thyroid cancer often carries far less fear in medical circles than it does among patients, largely because, when detected early, it is among the most treatable cancers. The thyroid gland, a small ...

JACKSONVILLE, Fla. — In Jacksonville Thursday, Florida Gov. Ron DeSantis announced that new forms of radiation treatment for cancer patients are coming soon to Mayo Clinic in the next two years. The ...

Verzenio monotherapy provided clinical benefits to 33% of patients with HR-positive, HER2-negative breast cancer after prior CDK4/6 inhibitor therapy. The rAMBER study highlights Verzenio's potential ...

A US study of more than a million Medicaid enrollees newly diagnosed with opioid use disorder (OUD), finds most—nearly seven in 10—are not receiving access to potentially life-saving drugs within six ...

Outcomes of Patients With Rare Cancers Treated With Combination Immune Checkpoint Inhibitors With and Without Previous Anti–PD-1/L1 Exposure: National Cancer Institute/SWOG S1609 Surveys were ...

Over six months, more than 60 people receiving medication-assisted treatment for opioid use disorder answered surveys on their smartphones about their mental health, psychological state and ...

Ruxolitinib Versus Best Available Therapy in Patients With Steroid-Refractory Acute Graft-Versus-Host Disease: Final Analysis From the Randomized Phase III REACH2 Trial In the phase III ...

Congress may lock in federal spending that fails to keep up with economic and population growth for the second year in a row, potentially leading to historically low levels. Disagreements over the ...

(Barcelona, Spain September 6, 2025, 5:45 p.m. CEST / UTC +2 ) — A new analysis from the COMPEL trial shows that patients with EGFR-mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) who ...